(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/11/22 | 日証協 | 273,453株 | -0.28% | 2,134株 | -40.31% | 526,446株 | +0.01% | 15,244株 | -15.9% |
2024/11/15 | 日証協 | 274,220株 | +5.34% | 3,575株 | -51.83% | 526,417株 | -1.09% | 18,126株 | -25.13% |
2024/11/08 | 日証協 | 260,321株 | -1.25% | 7,421株 | +695.39% | 532,202株 | +0.86% | 24,210株 | -34.56% |
2024/11/01 | 日証協 | 263,619株 | -2.66% | 933株 | -74.75% | 527,658株 | +1.75% | 36,997株 | +10.57% |
2024/10/25 | 日証協 | 270,819株 | -8.8% | 3,695株 | -95.61% | 518,594株 | -3.23% | 33,459株 | -43.07% |
2024/10/18 | 日証協 | 296,952株 | +0.24% | 84,183株 | +4561.3% | 535,887株 | +0.28% | 58,776株 | -1.13% |
2024/10/11 | 日証協 | 296,251株 | -15.44% | 1,806株 | -98.93% | 534,396株 | -5.38% | 59,445株 | -38.2% |
2024/10/04 | 日証協 | 350,351株 | +8.48% | 169,081株 | +106.16% | 564,802株 | -1.3% | 96,195株 | +4.91% |
2024/09/27 | 日証協 | 322,964株 | +2.54% | 82,015株 | +987.3% | 572,216株 | +0.57% | 91,692株 | -8.5% |
2024/09/20 | 日証協 | 314,964株 | -5.43% | 7,543株 | -90.52% | 568,966株 | -1.31% | 100,209株 | -19.97% |
2024/09/13 | 日証協 | 333,064株 | -17.45% | 79,546株 | -57.5% | 576,529株 | -2.05% | 125,209株 | -2.27% |
2024/09/06 | 日証協 | 403,465株 | +39% | 187,160株 | +3946.7% | 588,583株 | -1.36% | 128,111株 | -8% |
2024/08/30 | 日証協 | 290,264株 | -1.75% | 4,625株 | +25.24% | 596,722株 | +0.51% | 139,250株 | +3.06% |
2024/08/23 | 日証協 | 295,431株 | -2.86% | 3,693株 | -94.87% | 593,698株 | -1.09% | 135,118株 | -17.5% |
2024/08/16 | 日証協 | 304,131株 | -21.05% | 71,939株 | -73.6% | 600,224株 | -7.74% | 163,772株 | +36.98% |
2024/08/09 | 日証協 | 385,243株 | +1.87% | 272,480株 | +317.55% | 650,544株 | -1.19% | 119,561株 | -23.44% |
2024/08/02 | 日証協 | 378,166株 | -8.45% | 65,257株 | -51.62% | 658,346株 | -3.27% | 156,167株 | -37.16% |
2024/07/26 | 日証協 | 413,066株 | +0.27% | 134,880株 | -59.43% | 680,575株 | -3.42% | 248,517株 | +32.22% |
2024/07/19 | 日証協 | 411,942株 | +36.66% | 332,501株 | +160.31% | 704,672株 | -3.49% | 187,964株 | +18.01% |
※株式分割は考慮していませんのでご注意ください。
Page Top